Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS - Acquisition of Beacon Bio (Details)

v3.22.1
ACQUISITIONS - Acquisition of Beacon Bio (Details) - USD ($)
$ in Millions
1 Months Ended
Jun. 10, 2021
Jul. 31, 2020
Business Acquisition [Line Items]    
Vesting period   4 years
Beacon Bio    
Business Acquisition [Line Items]    
Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable $ 6.1  
Asset Acquisition, Equity Interest Issued or Issuable, Number of Shares 334,370  
Asset Acquisition, Payment made at Closing $ 0.2  
Additional payment $ 1.0  
Vesting period 3 years  
Common Stock | Beacon Bio    
Business Acquisition [Line Items]    
Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable $ 4.3